# FDA Inspection 1161078 - Bi-Coastal Pharma International - January 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/bi-coastal-pharma-international/22b8b76f-f16b-4d9d-af96-e43b2e232e7a
Source feed: FDA_Inspections

> FDA Inspection 1161078 for Bi-Coastal Pharma International on January 14, 2022. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1161078
- Company Name: Bi-Coastal Pharma International
- Inspection Date: 2022-01-14
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1129470 - 2020-09-14](https://www.keypedia.com/records/fda_inspections/bi-coastal-pharma-international/c27ef8a7-8641-465a-9eaa-d4733a246797)

Company: https://www.keypedia.com/companies/bi-coastal-pharma-international/38b9fd58-5145-4f23-9c94-1ba900477ef2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c